Search results with tag "Bc cancer"
Guidebook for Patients - BC Cancer
www.bccancer.bc.ca2 BC Cancer Agency Guidebook for Patients BC Cancer Agency Guidebook for Patients 3 Where is the BC Cancer Agency centre where I will receive treatment?
Radiation Therapy - BC Cancer
www.bccancer.bc.caradiation therapy, what to expect 3 Contents This booklet was made possible through the generosity of BC Cancer Foundation donors. The BC Cancer Foundation is the fundraising partner of
DRUG NAME: Pazopanib - BC Cancer
www.bccancer.bc.caPazopanib BC Cancer Agency Cancer Drug Manual© Page 1 of 7 Pazopanib Developed: 1 October 2011 Revised: 1 October 2015 DRUG NAME: Pazopanib SYNONYM(S): pazopanib hydrochloride, GW7860341 COMMON TRADE NAME(S):
DRUG NAME: BCG - BC Cancer
www.bccancer.bc.caBCG DRUG NAME: BCG SYNONYM(S): Bacillus Calmette-Guérin1 COMMON TRADE NAME(S): IMMUCYST®, OncoTICE®, THERACYC® (USA), TICE® (USA) CLASSIFICATION: biological response modifier Special pediatric considerations are noted when applicable, otherwise adult provisions apply.
DRUG NAME: Fluorouracil - BC Cancer
www.bccancer.bc.caFluorouracil BC Cancer Agency Cancer Drug Manual© Page 1 of 11 Fluorouracil Developed: September 1994 Revised: June 2006 Limited revision: 1 September 2015 DRUG NAME: Fluorouracil
Colon Screening Program - BC Cancer
www.bccancer.bc.ca3 Colon Screening Program Patient Coordinator Standards 22 Mar 2016 (R) Acknowledgements The BC Cancer Agency (BCCA) would like to thank everyone who assisted in the development and
DRUG NAME: Bleomycin - BC Cancer
www.bccancer.bc.caBleomycin BC Cancer Agency Cancer Drug Manual© Page 1 of 10 Bleomycin Developed: September 1994 Revised: 1 May 2007 Limited Revision: 1 March 2009, 1 June 2013, 1 December 2014
Symptom Management Guidelines: CARE OF ... - BC Cancer
www.bccancer.bc.caUnderstanding / Impact on You ... Treatments may include: surgery, chemotherapy, radiotherapy and hormone manipulation Co-morbid conditions such as COPD, diabetes, or heart disease may put the patient at risk for ... The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views ...
For Health Professionals Who Care For Cancer …
www.bccancer.bc.caBC Cancer Agency ♦ Provincial Systemic Therapy Program Update ♦ Vol. 18 No. 9 2015 ♦ Page 1 . For Health Professionals Who Care For Cancer Patients
PATIENT ASSISTANCE PROGRAMS
www.bccancer.bc.caPATIENT ASSISTANCE PROGRAMS . Definitions BCCA. BC Cancer Agency . SAP. Health Canada Special Access Program . Class I. Reimbursed for active cancer or approved treatment or approved indication only
For Health Professionals Who Care For Cancer Patients
www.bccancer.bc.ca– The BC Cancer Lymphoma Group is introducing ibrutinib as a new treatment for patients with relapsed after or refractory to standard treatments.
Financial Information for Cancer Patients
www.bccancer.bc.caIntroduction This pamphlet was created by BC Cancer Agency, Psychosocial Oncology Programs and is meant as a guide to help you and your family learn about support programs
DRUG NAME: Carboplatin - BC Cancer
www.bccancer.bc.caCarboplatin Myelosuppression is the dose-limiting toxicity, usually manifested as thrombocytopenia and less commonly as leukopenia, neutropenia and anemia. Risk factors include prior cytotoxic therapy (especially cisplatin), poor performance status, old age, impaired renal function and concurrent myelosuppressive therapy.
DRUG NAME: Ifosfamide - BC Cancer
www.bccancer.bc.caIfosfamide DRUG NAME: Ifosfamide SYNONYM(S): isophosphamide,1 iphosphamide2 COMMON TRADE NAME(S): IFEX® CLASSIFICATION: alkylating agent, cytotoxic3 Special pediatric considerations are noted when …
DRUG NAME: VINCRISTINE - BC Cancer
www.bccancer.bc.caVincristine Hyperuricemia during periods of active cell lysis, which is caused by cytotoxic chemotherapy of highly proliferative tumours of massive burden (e.g., some leukemias and lymphomas), can be minimized with allopurinol and hydration. However, fluid restriction may be required for a patient showing signs of SIADH.
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
DRUG NAME: Oxaliplatin - BC Cancer
www.bccancer.bc.caOxaliplatin DRUG NAME: Oxaliplatin SYNONYM(S): ACT -078, l OHP, LOHP, oxalatoplatin, oxaliplatinum COMMON TRADE NAME(S): ELOXATIN CLASSIFICATION: Alkylating agent Special pediatric considerations are noted when applicable, otherwise adult provisions apply.
DRUG NAME: AMIFOSTINE - BC Cancer
www.bccancer.bc.caAdapted from reference 2 unless specified otherwise.. Hypotension is usually asymptomatic but rarely causes dizziness or fainting. It may be associated with dyspnea, apnea, hypoxia, and rarely, seizures, loss of consciousness, respiratory arrest or …
CANCER DRUG PHARMACOLOGY TABLE
www.bccancer.bc.caBC Cancer Pharmacy Education Program Cancer Drug Pharmacology Table 1/10 Author: Rhonda Kalyn, BC Cancer Reviewer: Mario de Lemos, BC Cancer Published: 2018-02-06 ... topotecan Topoisomerase II amsacrine anthracyclines - daunorubicin doxorubicin (regular and pegylated liposomal) - epirubicin - idarubicin ...
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
BC Cancer Protocol Summary for Palliative Therapy …
www.bccancer.bc.caBC Cancer Protocol Summary for Palliative Therapy for Metastatic Breast Cancer Using PERTuzumab, Trastuzumab (HERCEPTIN), and PACLItaxel as First-Line Treatment for Advanced Breast Cancer
BC Cancer Protocol Summary for Palliative Combination ...
www.bccancer.bc.caBC Cancer Protocol Summary GIFOLFOX Page 1 of 8 Activated: 16 Sep 2002 Revised: 1 Jan 2022 (Treatment updated) Warning: The information contained in these documents are a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment.
BC Cancer Protocol Summary for Treatment of Hodgkin ...
www.bccancer.bc.caBC Cancer Protocol Summary LYABVD Page 1 of 4 Activated: 1 Jan 1993 Revised: 1 Mar 2022 (IV bag and in-line filter clarified) Warning: The information contained in these documents are a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment.
BC Cancer Protocol Summary for Palliative Combination ...
www.bccancer.bc.caBC Cancer Protocol Summary for Palliative Combination Chemotherapy for Metastatic Colorectal Cancer Using Oxaliplatin, Fluorouracil, Leucovorin, and PANitumumab
BC Cancer Protocol Summary for Therapy of …
www.bccancer.bc.caWarning: The information contained in these documents are a statement of consensus of BC Cancer professionals regarding their views …
BC Cancer Protocol Summary for Central Nervous System ...
www.bccancer.bc.caBC Cancer Protocol Summary for Central Nervous System Prophylaxis with High Dose Methotrexate, CHOP and riTUXimab in Diffuse Large B-cell Lymphoma
BC Cancer Protocol Summary for Primary Treatment …
www.bccancer.bc.caSYSTEMIC TREATMENT (give PACLitaxel first): . Drug Starting Dose BC Cancer Administration Standard PACLItaxel 175 mg/m2 * IV in 500 mL NS over 3 hours (use non-DEHP bag and non DEHP tubing - with 0.22 micron or smaller in-line filter)
BC Cancer Extravasation Hazard Table
www.bccancer.bc.catopotecan . trastuzumab . zoledronic acid *Follow guidelines and treat like a vesicant. **Some case reports of extravasation and injection site reactions or inflammation have been reported. For definitions of different categories of extravasation hazard and the details on management of extravasation, see BC Cancer Systemic Therapy Policy III-20
Similar queries
Guidebook for Patients, BC Cancer, Guidebook for Patients BC Cancer, Radiation Therapy - BC Cancer, Radiation therapy, DRUG NAME: Pazopanib, BC Cancer Agency Cancer Drug, NAME, DRUG NAME: BCG, DRUG NAME: Fluorouracil, Cancer Drug, Colon Screening Program, BC Cancer Agency, DRUG NAME: Bleomycin, Bleomycin BC Cancer Agency Cancer, Bleomycin, Understanding, Chemotherapy, For Health Professionals Who Care For Cancer, Therapy, PATIENT ASSISTANCE PROGRAMS, Cancer, Programs, DRUG NAME: Carboplatin, DRUG NAME, Ifosfamide, Ifosfamide DRUG NAME, Vincristine, Patient, Magic” mouthwash explained, FAMILY PRACTICE ONCOLOGY, JOURNAL, Practice, DRUG NAME: AMIFOSTINE, Cancer Drug Pharmacology Table, Topotecan, Breast Cancer, PACLItaxel, BC Cancer Protocol Summary, Palliative Combination Chemotherapy for Metastatic, Oxaliplatin, Fluorouracil, Leucovorin, and PANitumumab